Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of AZD1305 intravenous infusion on left ventricular performance in patients with left ventricular dysfunction
2008-001254-41Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in left ventricular dysfunction comparing AZD1305 intravenous infusion with Placebo intravenous infusion (2 arms). Primary endpoint: Effect of AZD1305 on left ventricular performance. Started May 2008; status: completed.
02
Drugs
AZD-1305
03
Conditions
left ventricular dysfunction
Beyond the preview
Go deeper on 2008-001254-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001254-41.